Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-043859
Filing Date
2025-03-24
Accepted
2025-03-24 16:20:12
Documents
76
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K pali-20241231.htm   iXBRL 10-K 3520432
2 EX-23.1 pali-ex23_1.htm EX-23.1 4522
3 EX-31.1 pali-ex31_1.htm EX-31.1 18234
4 EX-31.2 pali-ex31_2.htm EX-31.2 18472
5 EX-32.1 pali-ex32_1.htm EX-32.1 9392
6 GRAPHIC img61919486_0.jpg GRAPHIC 216538
7 GRAPHIC img61919486_1.jpg GRAPHIC 398368
  Complete submission text file 0000950170-25-043859.txt   12881000

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT pali-20241231.xsd EX-101.SCH 1392431
78 EXTRACTED XBRL INSTANCE DOCUMENT pali-20241231_htm.xml XML 1728740
Mailing Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009
Business Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009 (858) 704-4900
PALISADE BIO, INC. (Filer) CIK: 0001357459 (see all company filings)

EIN.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33672 | Film No.: 25764402
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)